Xie H, Bevan J A
Totman Laboratory for Cerebrovascular Research, Department of Pharmacology, College of Medicine, University of Vermont, Burlington 05405-0068, USA.
Stroke. 1999 Nov;30(11):2423-29; discussion 2429-30. doi: 10.1161/01.str.30.11.2423.
Cerebral arteries develop stretch-induced myogenic tone, which plays an important role in the regulation of blood flow to the brain. Although the effect of oxidized LDL (Ox-LDL) on many aspects of the vascular endothelial and smooth muscle cell function have been extensively investigated, its influence on myogenic activity has not been studied.
The effect of Ox-LDL on the myogenic tone that develops in the perfused rabbit posterior cerebral artery at intramural pressures between 40 and 90 mm Hg was examined.
Ox-LDL (10 microg/mL) significantly enhanced myogenic tone by 21.4+/-6.1% to 28.5+/-1.8% at 60 to 90 mm Hg pressure (P<0.05) but had no influence on norepinephrine- (0.5 to 1 micromol/L) and KCl (20 mmol/L)-induced constriction. Ox-LDL was effective whether the artery was exposed to it from the intraluminal or the extraluminal surface. Lysophosphatidylcholine (10 micromol/L), a lipid component of Ox-LDL, had an equivalent potentiating effect. Native LDL (100 microg/mL) was inactive. The myogenic tone-potentiating effect of Ox-LDL was abolished by endothelium removal but was not influenced by the NO synthase inhibitor N(G)-nitro-L-nitro-arginine methyl ester (50 micromol/L). This effect was reversed by the endothelin-1 (ET-1) antagonist BQ-123 (1 micromol/L). This concentration blocked 1 to 3 nmol/L ET-1-induced constriction without altering constriction induced by 40 mmol/L KCl. The potentiating effect was suppressed by the specific protein kinase C inhibitor chelerythrine (1 micromol/L).
Ox-LDL enhances myogenic tone through the release of ET-1 from the endothelium of the rabbit posterior cerebral artery.
脑动脉可产生拉伸诱导的肌源性张力,这在调节脑血流中起重要作用。尽管氧化低密度脂蛋白(Ox-LDL)对血管内皮和平滑肌细胞功能诸多方面的影响已得到广泛研究,但其对肌源性活动的影响尚未见报道。
研究了Ox-LDL对灌注的兔大脑后动脉在40至90 mmHg壁内压时产生的肌源性张力的影响。
在60至90 mmHg压力下,Ox-LDL(10μg/mL)可使肌源性张力显著增强21.4±6.1%至28.5±1.8%(P<0.05),但对去甲肾上腺素(0.5至1μmol/L)和氯化钾(20 mmol/L)诱导的收缩无影响。无论动脉从管腔内还是管腔外表面接触Ox-LDL,其均有作用。溶血磷脂酰胆碱(10μmol/L),Ox-LDL的一种脂质成分,有同等的增强作用。天然低密度脂蛋白(100μg/mL)无活性。去除内皮后Ox-LDL的肌源性张力增强作用消失,但不受一氧化氮合酶抑制剂N(G)-硝基-L-精氨酸甲酯(50μmol/L)影响。内皮素-1(ET-1)拮抗剂BQ-123(1μmol/L)可逆转此作用。该浓度可阻断1至3 nmol/L ET-1诱导的收缩,而不改变40 mmol/L氯化钾诱导的收缩。特异性蛋白激酶C抑制剂白屈菜红碱(1μmol/L)可抑制这种增强作用。
Ox-LDL通过从兔大脑后动脉内皮释放ET-1增强肌源性张力。